Eratrectinib
Eratrectinib (Example 1) is a Trk inhibitor. Eratrectinib can be studied in research for tropomyosin receptor kinase-related diseases and cancers[1].
Product Specifications
CAS Number
2396516-98-4
UNSPSC
12352005
Target
Trk Receptor
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
FC(C=C1[C@]2([H])N(CCC2)C3=NC4=C5C=NN4C=C3)=CN=C1CCN(C6CC6)NC5=O
Molecular Formula
C21H22FN7O
Molecular Weight
407.44
References & Citations
[1]Yong Wu, et al., Pyrazolo[1,5-a]pyrimidine derivatives as tropomyosin receptor kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO2019233461A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
23173141 1x 10^6 Cells / 1.0 mL
HECTD3 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details 